BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34708891)

  • 1. miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway.
    Li R; Hu Z; Wang Z; Zhu T; Wang G; Gao B; Wang J; Deng X
    J Clin Lab Anal; 2021 Dec; 35(12):e24078. PubMed ID: 34708891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MIR4435-2HG functions as a ceRNA against miR-125a-5p and promotes neuroglioma development by upregulating TAZ.
    Shen W; Zhang J; Pan Y; Jin Y
    J Clin Lab Anal; 2021 Dec; 35(12):e24066. PubMed ID: 34714963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
    Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
    Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway.
    Cao Y; Shen T; Zhang C; Zhang QH; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8249-8256. PubMed ID: 31646555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ.
    Tang L; Zhou L; Wu S; Shi X; Jiang G; Niu S; Ding D
    Onco Targets Ther; 2019; 12():3481-3489. PubMed ID: 31190857
    [No Abstract]   [Full Text] [Related]  

  • 6. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
    Zhang Y; Bai J; Cheng R; Zhang D; Qiu Z; Liu T; Che N; Dong X; Zhao N; Lin X; Liang X; Li F; Li Y; Sun B; Zhao X
    J Gastroenterol Hepatol; 2022 Apr; 37(4):714-726. PubMed ID: 35062042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.
    Huang J; He Y; Mcleod HL; Xie Y; Xiao D; Hu H; Chen P; Shen L; Zeng S; Yin X; Ge J; Li L; Tang L; Ma J; Chen Z
    BMC Cancer; 2017 Dec; 17(1):886. PubMed ID: 29273006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
    Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
    Wang H; Di X; Bi Y; Sun S; Wang T
    Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
    Song J; Liu Y; Wang T; Li B; Zhang S
    Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
    Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
    Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer.
    Wang L; Li B; Zhang L; Li Q; He Z; Zhang X; Huang X; Xu Z; Xia Y; Zhang Q; Li Q; Xu J; Sun G; Xu Z
    Cell Prolif; 2019 May; 52(3):e12567. PubMed ID: 30883979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA TNK2 AS1/microRNA-125a-5p axis promotes tumor growth and modulated phosphatidylinositol 3 kinase/AKT pathway.
    Guo L; Ma H; Kong Y; Leng G; Liu G; Zhang Y
    J Gastroenterol Hepatol; 2022 Jan; 37(1):124-133. PubMed ID: 34494305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0001829 promotes gastric cancer progression through miR-155-5p/SMAD2 axis.
    Niu Q; Dong Z; Liang M; Luo Y; Lin H; Lin M; Zhong X; Yao W; Weng J; Zhou X
    J Exp Clin Cancer Res; 2020 Dec; 39(1):280. PubMed ID: 33308284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2.
    Qi M; Jiao M; Li X; Hu J; Wang L; Zou Y; Zhao M; Zhang R; Liu H; Mi J; Zhang L; Liu L; Gong Y; Han B
    Oncogene; 2018 Feb; 37(8):1075-1085. PubMed ID: 29106389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
    Peng Y; Zhang X; Lin H; Deng S; Qin Y; Yuan Y; Feng X; Wang J; Chen W; Hu F; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Li S; Meltzer SJ; Jin Z
    Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia.
    Fang X; Bai Y; Zhang L; Ding S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
    Yan L; Zhang J; Guo D; Ma J; Shui SF; Han XW
    Int J Oncol; 2019 Jan; 54(1):7-16. PubMed ID: 30387833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.